ScienceDex / Researcher record
Campen, Matthew J
- University of New Mexico Health Sciences Center · Pharmacology (NIH department code)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Top 5% Funded
- R01 Holder
- Long-Funded
- Diverse Portfolio
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2008 | $461,250 | 1 | #15,078 |
| 2009 | $461,250 | 2 | #18,902 |
| 2010 | $331,739 | 1 | #25,867 |
| 2011 | $329,033 | 1 | #23,652 |
| 2012 | $329,277 | 1 | #23,998 |
| 2013 | $374,556 | 2 | #19,246 |
| 2014 | $555,607 | 2 | #13,946 |
| 2015 | $854,226 | 2 | #8,257 |
| 2016 | $1,744,363 | 4 | #3,283 |
| 2017 | $1,944,553 | 4 | #2,794 |
| 2018 | $1,998,441 | 4 | #2,859 |
| 2019 | $1,153,225 | 3 | #6,794 |
| 2020 | $2,521,061 | 1 | #592 |
| 2021 | $4,282,496 | 6 | #924 |
| 2022 | $4,402,632 | 6 | #900 |
| 2023 | $3,936,398 | 4 | #1,134 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20081 record
- FY20092 records
- FY20101 record
- FY20111 record
- FY20121 record
- FY20132 records
- FY20142 records
- FY20152 records
- FY20164 records
- FY20174 records
- FY20184 records
- FY20193 records
- FY20201 record
- FY20216 records
- FY2022 · selected6 records
- FY20234 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
FY2022 award records by amount
NIH award records listing Campen, Matthew J as a PI. Multi-PI records show the full award amount for context.
- 5P20GM130422-03P20Contact PIUniversity of New Mexico Center for Metals in Biology and MedicineUniversity of New Mexico Health Sciences Center · Pharmacology (NIH department code)$2.3Maward amount
- 1R01AG070776-01A1R01Contact PIAcceleration of Circulatory and Neurological Aging due to Wildfire ExposuresUniversity of New Mexico Health Sciences Center · Pharmacology (NIH department code)$793.9Kaward amount
- 3P20GM130422-03S1P20Contact PISARS-CoV-2 Genomic Surveillance and Epidemiology in New MexicoUniversity of New Mexico Health Sciences Center · Pharmacology (NIH department code)$762.1Kaward amount
- 5R01ES014639-15R01Contact PIMechanisms of Vascular Toxicity from Inhaled ToxicantsUniversity of New Mexico Health Sciences Center · Pharmacology (NIH department code)$324.6Kaward amount
- 3P20GM130422-03S2P20Contact PIUniversity of New Mexico Center for Metals in Biology and Medicine - equipment supplementUniversity of New Mexico Health Sciences Center · Pharmacology (NIH department code)$250Kaward amount
- 1R13ES034641-01R13Contact PI13th International Particle Toxicology MeetingUniversity of New Mexico Health Sciences Center · Pharmacology (NIH department code)$10Kaward amount
Award organization
Organizations that administered FY2022 awards listing Campen, Matthew J as a PI.
FY2022 award administered by University of New Mexico Health Sciences Center (NM).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardUniversity of New Mexico Health Sciences Center
- 2009$500K Cumulative Funding
- 2010$1M Cumulative Funding
- 2013$2M Cumulative Funding
- 2013R01 Grant Holder
- 2015Entered Top 50% NationallyRanked #8257
- 2016$5M Cumulative Funding
- 2016Entered Top 25% NationallyRanked #3283
- 2019$10M Cumulative Funding
- 2020Entered Top 10% NationallyRanked #592
- 2020Entered Top 5% NationallyRanked #592
- 2023$25M Cumulative Funding